According to the Deputy director of the FDA"s Office of New Drugs at the Center for Drug Evaluation and Research, Dr Sandra KwederI, the top recommendation of the advisory panel was that the agency needs to address and decrease the usual dose of acetaminophen, both for over-the-counter products and also prescription combination products. The FDA panel suggests banning Percocet [oxycodone and acetaminophen] and Vicodin [hydrocodone bitartrate and acetaminophen]which experts say would not be drastic due to other drugs being available.
저작권자 © 메디칼업저버 무단전재 및 재배포 금지